Systematic Review Initiative
@sritransfusion.bsky.social
Improving the evidence base for the practice of #transfusionmedicine through undertaking and supporting others in undertaking #systematicreviews. Active since 2002.
www.systematicreviewinitiative.com
Our Twitter site closed at the end of 2024
www.systematicreviewinitiative.com
Our Twitter site closed at the end of 2024
Pinned
New #systematicreview by the SRI:
ABO matching for platelet transfusions for prevention or treatment of bleeding: A systematic review with #metaanalysis by Cain et al.
Access the article at @transfusionlib.bsky.social
www.transfusionevidencelibrary.com/alerts/artic...
ABO matching for platelet transfusions for prevention or treatment of bleeding: A systematic review with #metaanalysis by Cain et al.
Access the article at @transfusionlib.bsky.social
www.transfusionevidencelibrary.com/alerts/artic...
New #systematicreview by the SRI:
ABO matching for platelet transfusions for prevention or treatment of bleeding: A systematic review with #metaanalysis by Cain et al.
Access the article at @transfusionlib.bsky.social
www.transfusionevidencelibrary.com/alerts/artic...
ABO matching for platelet transfusions for prevention or treatment of bleeding: A systematic review with #metaanalysis by Cain et al.
Access the article at @transfusionlib.bsky.social
www.transfusionevidencelibrary.com/alerts/artic...
November 27, 2025 at 1:55 PM
New #systematicreview by the SRI:
ABO matching for platelet transfusions for prevention or treatment of bleeding: A systematic review with #metaanalysis by Cain et al.
Access the article at @transfusionlib.bsky.social
www.transfusionevidencelibrary.com/alerts/artic...
ABO matching for platelet transfusions for prevention or treatment of bleeding: A systematic review with #metaanalysis by Cain et al.
Access the article at @transfusionlib.bsky.social
www.transfusionevidencelibrary.com/alerts/artic...
Reposted by Systematic Review Initiative
New from #StemCellEvidence:
Peripheral Blood or Bone Marrow Grafts for Mismatched Unrelated Donors with Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
by Arcuri et al.
www.stemcellevidence.com/articles/410...
#MedSky
Peripheral Blood or Bone Marrow Grafts for Mismatched Unrelated Donors with Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
by Arcuri et al.
www.stemcellevidence.com/articles/410...
#MedSky
November 25, 2025 at 5:26 PM
New from #StemCellEvidence:
Peripheral Blood or Bone Marrow Grafts for Mismatched Unrelated Donors with Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
by Arcuri et al.
www.stemcellevidence.com/articles/410...
#MedSky
Peripheral Blood or Bone Marrow Grafts for Mismatched Unrelated Donors with Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
by Arcuri et al.
www.stemcellevidence.com/articles/410...
#MedSky
Reposted by Systematic Review Initiative
From the #StemCellEvidence Alert:
Baseline CD4+/CD8+ TEMRA Levels and Early Response Predict Survival After Umbilical Cord-Derived Mesenchymal Stem Cells Infusion in Acute GVHD Patients (...)
by Chin et al.
www.stemcellevidence.com/articles/410...
#MedSky
Baseline CD4+/CD8+ TEMRA Levels and Early Response Predict Survival After Umbilical Cord-Derived Mesenchymal Stem Cells Infusion in Acute GVHD Patients (...)
by Chin et al.
www.stemcellevidence.com/articles/410...
#MedSky
November 26, 2025 at 10:18 AM
From the #StemCellEvidence Alert:
Baseline CD4+/CD8+ TEMRA Levels and Early Response Predict Survival After Umbilical Cord-Derived Mesenchymal Stem Cells Infusion in Acute GVHD Patients (...)
by Chin et al.
www.stemcellevidence.com/articles/410...
#MedSky
Baseline CD4+/CD8+ TEMRA Levels and Early Response Predict Survival After Umbilical Cord-Derived Mesenchymal Stem Cells Infusion in Acute GVHD Patients (...)
by Chin et al.
www.stemcellevidence.com/articles/410...
#MedSky
Reposted by Systematic Review Initiative
New from #StemCellEvidence:
Allogeneic hematopoietic cell transplant in cutaneous T-cell lymphomas: recommendations from the EBMT PH&G Committee
by Damaj et al.
www.stemcellevidence.com/articles/410...
#MedSky
Allogeneic hematopoietic cell transplant in cutaneous T-cell lymphomas: recommendations from the EBMT PH&G Committee
by Damaj et al.
www.stemcellevidence.com/articles/410...
#MedSky
November 27, 2025 at 7:40 AM
New from #StemCellEvidence:
Allogeneic hematopoietic cell transplant in cutaneous T-cell lymphomas: recommendations from the EBMT PH&G Committee
by Damaj et al.
www.stemcellevidence.com/articles/410...
#MedSky
Allogeneic hematopoietic cell transplant in cutaneous T-cell lymphomas: recommendations from the EBMT PH&G Committee
by Damaj et al.
www.stemcellevidence.com/articles/410...
#MedSky
Reposted by Systematic Review Initiative
The #Transfusion Evidence Alert - November 2025 is out!
Each month our clinical team picks the ten top references in the #transfusionmedicine field.
Sign up to get the alert in your inbox: www.transfusionevidencelibrary.com/alerts/latest
#MedSky
Each month our clinical team picks the ten top references in the #transfusionmedicine field.
Sign up to get the alert in your inbox: www.transfusionevidencelibrary.com/alerts/latest
#MedSky
November 26, 2025 at 10:19 AM
The #Transfusion Evidence Alert - November 2025 is out!
Each month our clinical team picks the ten top references in the #transfusionmedicine field.
Sign up to get the alert in your inbox: www.transfusionevidencelibrary.com/alerts/latest
#MedSky
Each month our clinical team picks the ten top references in the #transfusionmedicine field.
Sign up to get the alert in your inbox: www.transfusionevidencelibrary.com/alerts/latest
#MedSky
Reposted by Systematic Review Initiative
The #StemCellEvidence monthly alert is out!
See all the top 10 articles here:
www.stemcellevidence.com/alerts/latest
Each one has an easy-to-read PICO summary.
#MedSky
See all the top 10 articles here:
www.stemcellevidence.com/alerts/latest
Each one has an easy-to-read PICO summary.
#MedSky
November 24, 2025 at 11:33 AM
The #StemCellEvidence monthly alert is out!
See all the top 10 articles here:
www.stemcellevidence.com/alerts/latest
Each one has an easy-to-read PICO summary.
#MedSky
See all the top 10 articles here:
www.stemcellevidence.com/alerts/latest
Each one has an easy-to-read PICO summary.
#MedSky
Reposted by Systematic Review Initiative
New from #Transfusion Evidence Library:
The effect of intravenous iron supplementation compared to oral iron supplementation during pregnancy on neonatal outcomes-a #systematicreview of randomized controlled trials
by Kuitunen et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
The effect of intravenous iron supplementation compared to oral iron supplementation during pregnancy on neonatal outcomes-a #systematicreview of randomized controlled trials
by Kuitunen et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
November 27, 2025 at 1:26 PM
New from #Transfusion Evidence Library:
The effect of intravenous iron supplementation compared to oral iron supplementation during pregnancy on neonatal outcomes-a #systematicreview of randomized controlled trials
by Kuitunen et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
The effect of intravenous iron supplementation compared to oral iron supplementation during pregnancy on neonatal outcomes-a #systematicreview of randomized controlled trials
by Kuitunen et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Reposted by Systematic Review Initiative
New from #Transfusion Evidence Library:
Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously untreated or minimally treated children with hemophilia A or B
by Razmpoosh et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously untreated or minimally treated children with hemophilia A or B
by Razmpoosh et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
November 3, 2025 at 10:05 AM
New from #Transfusion Evidence Library:
Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously untreated or minimally treated children with hemophilia A or B
by Razmpoosh et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously untreated or minimally treated children with hemophilia A or B
by Razmpoosh et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Reposted by Systematic Review Initiative
New from #StemCellEvidence:
Impact of Dara-VTD induction therapy on stem cell mobilization outcomes in newly diagnosed multiple myeloma patients undergoing autologous stem cell transplantation: a multicenter study
by Della Pepa et al.
www.stemcellevidence.com/articles/409...
#MedSky
Impact of Dara-VTD induction therapy on stem cell mobilization outcomes in newly diagnosed multiple myeloma patients undergoing autologous stem cell transplantation: a multicenter study
by Della Pepa et al.
www.stemcellevidence.com/articles/409...
#MedSky
November 3, 2025 at 9:43 AM
New from #StemCellEvidence:
Impact of Dara-VTD induction therapy on stem cell mobilization outcomes in newly diagnosed multiple myeloma patients undergoing autologous stem cell transplantation: a multicenter study
by Della Pepa et al.
www.stemcellevidence.com/articles/409...
#MedSky
Impact of Dara-VTD induction therapy on stem cell mobilization outcomes in newly diagnosed multiple myeloma patients undergoing autologous stem cell transplantation: a multicenter study
by Della Pepa et al.
www.stemcellevidence.com/articles/409...
#MedSky
Reposted by Systematic Review Initiative
Delighted to accept the ISBT Award with Dr Allison Mo on behalf of the ISBT-SRI Transfusion Evidence Round-Up team this week in Perth!
@isbt.bsky.social @sritransfusion.bsky.social
More info on the Transfusion Evidence Round-Ups: www.isbtweb.org/resources/isbt-sri-transfusion-round-up.html
@isbt.bsky.social @sritransfusion.bsky.social
More info on the Transfusion Evidence Round-Ups: www.isbtweb.org/resources/isbt-sri-transfusion-round-up.html
October 28, 2025 at 3:03 PM
Delighted to accept the ISBT Award with Dr Allison Mo on behalf of the ISBT-SRI Transfusion Evidence Round-Up team this week in Perth!
@isbt.bsky.social @sritransfusion.bsky.social
More info on the Transfusion Evidence Round-Ups: www.isbtweb.org/resources/isbt-sri-transfusion-round-up.html
@isbt.bsky.social @sritransfusion.bsky.social
More info on the Transfusion Evidence Round-Ups: www.isbtweb.org/resources/isbt-sri-transfusion-round-up.html
Reposted by Systematic Review Initiative
From the #Transfusion Evidence Alert:
Comparative efficacy and safety of different #tranexamicacid administration in spine surgery: a network meta-analysis
by Zheng et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Comparative efficacy and safety of different #tranexamicacid administration in spine surgery: a network meta-analysis
by Zheng et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
October 13, 2025 at 7:06 AM
From the #Transfusion Evidence Alert:
Comparative efficacy and safety of different #tranexamicacid administration in spine surgery: a network meta-analysis
by Zheng et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Comparative efficacy and safety of different #tranexamicacid administration in spine surgery: a network meta-analysis
by Zheng et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Reposted by Systematic Review Initiative
From the #StemCellEvidence Alert:
Long-Term Efficacy of Epstein-Barr Virus-Specific T Cells for Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation (...)
by Sun et al.
www.stemcellevidence.com/articles/408...
#MedSky
Long-Term Efficacy of Epstein-Barr Virus-Specific T Cells for Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation (...)
by Sun et al.
www.stemcellevidence.com/articles/408...
#MedSky
October 13, 2025 at 8:55 AM
From the #StemCellEvidence Alert:
Long-Term Efficacy of Epstein-Barr Virus-Specific T Cells for Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation (...)
by Sun et al.
www.stemcellevidence.com/articles/408...
#MedSky
Long-Term Efficacy of Epstein-Barr Virus-Specific T Cells for Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation (...)
by Sun et al.
www.stemcellevidence.com/articles/408...
#MedSky
Reposted by Systematic Review Initiative
New from #Transfusion Evidence Library:
Efficacy and safety of different treatments in chemotherapy-induced thrombocytopenia: a #systematicreview and network meta-analysis
by Yang et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Efficacy and safety of different treatments in chemotherapy-induced thrombocytopenia: a #systematicreview and network meta-analysis
by Yang et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
October 10, 2025 at 12:13 PM
New from #Transfusion Evidence Library:
Efficacy and safety of different treatments in chemotherapy-induced thrombocytopenia: a #systematicreview and network meta-analysis
by Yang et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Efficacy and safety of different treatments in chemotherapy-induced thrombocytopenia: a #systematicreview and network meta-analysis
by Yang et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Reposted by Systematic Review Initiative
New from #StemCellEvidence:
Narsoplimab Results in Excellent Survival in Adults and Children With Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy (TA-TMA)
by Schoettler et al.
www.stemcellevidence.com/articles/408...
#MedSky
Narsoplimab Results in Excellent Survival in Adults and Children With Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy (TA-TMA)
by Schoettler et al.
www.stemcellevidence.com/articles/408...
#MedSky
October 10, 2025 at 12:32 PM
New from #StemCellEvidence:
Narsoplimab Results in Excellent Survival in Adults and Children With Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy (TA-TMA)
by Schoettler et al.
www.stemcellevidence.com/articles/408...
#MedSky
Narsoplimab Results in Excellent Survival in Adults and Children With Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy (TA-TMA)
by Schoettler et al.
www.stemcellevidence.com/articles/408...
#MedSky
New #systematicreview by the SRI:
#Bloodtransfusion strategies for major bleeding in trauma by Brunskill et al.
Access the article at @transfusionlib.bsky.social
www.transfusionevidencelibrary.com/articles/402...
#MedSky
#Bloodtransfusion strategies for major bleeding in trauma by Brunskill et al.
Access the article at @transfusionlib.bsky.social
www.transfusionevidencelibrary.com/articles/402...
#MedSky
September 19, 2025 at 12:31 PM
New #systematicreview by the SRI:
#Bloodtransfusion strategies for major bleeding in trauma by Brunskill et al.
Access the article at @transfusionlib.bsky.social
www.transfusionevidencelibrary.com/articles/402...
#MedSky
#Bloodtransfusion strategies for major bleeding in trauma by Brunskill et al.
Access the article at @transfusionlib.bsky.social
www.transfusionevidencelibrary.com/articles/402...
#MedSky
Reposted by Systematic Review Initiative
New Talking Transfusion episode!
For Blood Cancer Awareness month the hosts chat with reviewers from the Transfusion Evidence Roundup, exploring the latest findings, clinical challenges and highlight the importance of transfusion.
Listen here: open.spotify.com/episode/63YC...
#TalkingTransfusion
For Blood Cancer Awareness month the hosts chat with reviewers from the Transfusion Evidence Roundup, exploring the latest findings, clinical challenges and highlight the importance of transfusion.
Listen here: open.spotify.com/episode/63YC...
#TalkingTransfusion
Episode 4: Blood Cancer Awareness Month
open.spotify.com
September 18, 2025 at 8:35 AM
New Talking Transfusion episode!
For Blood Cancer Awareness month the hosts chat with reviewers from the Transfusion Evidence Roundup, exploring the latest findings, clinical challenges and highlight the importance of transfusion.
Listen here: open.spotify.com/episode/63YC...
#TalkingTransfusion
For Blood Cancer Awareness month the hosts chat with reviewers from the Transfusion Evidence Roundup, exploring the latest findings, clinical challenges and highlight the importance of transfusion.
Listen here: open.spotify.com/episode/63YC...
#TalkingTransfusion
Reposted by Systematic Review Initiative
New from the #Transfusion Evidence Round-Up: #BloodCancerAwarenessMonth 2025
Intravenous Iron Supplementation for the Treatment of Chemotherapy-Induced Anemia: A #SystematicReview and #MetaAnalysis of Randomized Controlled Trials
by Buchrits et al
www.transfusionevidencelibrary.com/articles/358...
Intravenous Iron Supplementation for the Treatment of Chemotherapy-Induced Anemia: A #SystematicReview and #MetaAnalysis of Randomized Controlled Trials
by Buchrits et al
www.transfusionevidencelibrary.com/articles/358...
September 19, 2025 at 7:59 AM
New from the #Transfusion Evidence Round-Up: #BloodCancerAwarenessMonth 2025
Intravenous Iron Supplementation for the Treatment of Chemotherapy-Induced Anemia: A #SystematicReview and #MetaAnalysis of Randomized Controlled Trials
by Buchrits et al
www.transfusionevidencelibrary.com/articles/358...
Intravenous Iron Supplementation for the Treatment of Chemotherapy-Induced Anemia: A #SystematicReview and #MetaAnalysis of Randomized Controlled Trials
by Buchrits et al
www.transfusionevidencelibrary.com/articles/358...
Reposted by Systematic Review Initiative
From the #StemCellEvidence Alert:
Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study
by Zeiser et al.
www.stemcellevidence.com/articles/405...
#MedSky
Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study
by Zeiser et al.
www.stemcellevidence.com/articles/405...
#MedSky
September 12, 2025 at 11:46 AM
From the #StemCellEvidence Alert:
Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study
by Zeiser et al.
www.stemcellevidence.com/articles/405...
#MedSky
Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study
by Zeiser et al.
www.stemcellevidence.com/articles/405...
#MedSky
Reposted by Systematic Review Initiative
New from #Transfusion Evidence Library:
Comparative efficacy and safety of rhTPO, romiplostim, and eltrombopag in the treatment of pediatric primary immune thrombocytopenia: a systematic review and network meta-analysis
by Zhang et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Comparative efficacy and safety of rhTPO, romiplostim, and eltrombopag in the treatment of pediatric primary immune thrombocytopenia: a systematic review and network meta-analysis
by Zhang et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
September 12, 2025 at 11:45 AM
New from #Transfusion Evidence Library:
Comparative efficacy and safety of rhTPO, romiplostim, and eltrombopag in the treatment of pediatric primary immune thrombocytopenia: a systematic review and network meta-analysis
by Zhang et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Comparative efficacy and safety of rhTPO, romiplostim, and eltrombopag in the treatment of pediatric primary immune thrombocytopenia: a systematic review and network meta-analysis
by Zhang et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Reposted by Systematic Review Initiative
New from #StemCellEvidence:
Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis
by Perales et al.
www.stemcellevidence.com/articles/406...
#MedSky
Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis
by Perales et al.
www.stemcellevidence.com/articles/406...
#MedSky
September 11, 2025 at 1:04 PM
New from #StemCellEvidence:
Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis
by Perales et al.
www.stemcellevidence.com/articles/406...
#MedSky
Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis
by Perales et al.
www.stemcellevidence.com/articles/406...
#MedSky
Reposted by Systematic Review Initiative
From the #Transfusion Evidence Alert:
Effectiveness of Prophylactic Tranexamic Acid in Reducing Blood Loss in Children Undergoing Open Nephrectomy for Wilms Tumor: A Randomized Controlled Study
by Verma et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Effectiveness of Prophylactic Tranexamic Acid in Reducing Blood Loss in Children Undergoing Open Nephrectomy for Wilms Tumor: A Randomized Controlled Study
by Verma et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
September 11, 2025 at 1:03 PM
From the #Transfusion Evidence Alert:
Effectiveness of Prophylactic Tranexamic Acid in Reducing Blood Loss in Children Undergoing Open Nephrectomy for Wilms Tumor: A Randomized Controlled Study
by Verma et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Effectiveness of Prophylactic Tranexamic Acid in Reducing Blood Loss in Children Undergoing Open Nephrectomy for Wilms Tumor: A Randomized Controlled Study
by Verma et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Reposted by Systematic Review Initiative
From the #StemCellEvidence Alert:
Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center
By Oran et al.
www.stemcellevidence.com/articles/407...
#MedSky
Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center
By Oran et al.
www.stemcellevidence.com/articles/407...
#MedSky
September 10, 2025 at 11:52 AM
From the #StemCellEvidence Alert:
Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center
By Oran et al.
www.stemcellevidence.com/articles/407...
#MedSky
Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center
By Oran et al.
www.stemcellevidence.com/articles/407...
#MedSky
Reposted by Systematic Review Initiative
New from #Transfusion Evidence Library:
Randomized Double-Blind Placebo-Controlled Trial of Desmopressin for Post-Kidney Biopsy Bleeding
by Prasad et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Randomized Double-Blind Placebo-Controlled Trial of Desmopressin for Post-Kidney Biopsy Bleeding
by Prasad et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
September 10, 2025 at 11:51 AM
New from #Transfusion Evidence Library:
Randomized Double-Blind Placebo-Controlled Trial of Desmopressin for Post-Kidney Biopsy Bleeding
by Prasad et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Randomized Double-Blind Placebo-Controlled Trial of Desmopressin for Post-Kidney Biopsy Bleeding
by Prasad et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Reposted by Systematic Review Initiative
New from #Transfusion Evidence Library:
Inhospital coagulation management and fluid replacement therapy in patients with multiple and/or severe injuries - a systematic review and clinical practice guideline update
by Lier et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Inhospital coagulation management and fluid replacement therapy in patients with multiple and/or severe injuries - a systematic review and clinical practice guideline update
by Lier et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
September 8, 2025 at 8:41 AM
New from #Transfusion Evidence Library:
Inhospital coagulation management and fluid replacement therapy in patients with multiple and/or severe injuries - a systematic review and clinical practice guideline update
by Lier et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Inhospital coagulation management and fluid replacement therapy in patients with multiple and/or severe injuries - a systematic review and clinical practice guideline update
by Lier et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Reposted by Systematic Review Initiative
From the #StemCellEvidence Alert:
Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia
by Levis et al.
www.stemcellevidence.com/articles/405...
#MedSky
Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia
by Levis et al.
www.stemcellevidence.com/articles/405...
#MedSky
September 8, 2025 at 8:43 AM
From the #StemCellEvidence Alert:
Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia
by Levis et al.
www.stemcellevidence.com/articles/405...
#MedSky
Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia
by Levis et al.
www.stemcellevidence.com/articles/405...
#MedSky